Who owns GT BIOPHARMA INC?
- CUSIP Number: 36254l209
Tip: Access positions for across all investors
Analyze quarterly positions in Gt Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Gt Biopharma stock
Who bought or sold GT BIOPHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 1.1M | $277k | 0% | Dec 2023 |
|
| Bank Of Montreal | 596k | $170k | 0% | Dec 2023 |
|
| Wells Fargo & Company | 301k | $77k | 0% | Dec 2023 |
|
| Atria Wealth Solutions | 99k | $25k | 11% | Dec 2023 |
|
| Millennium Management | 66k | $17k | -25% | Dec 2023 |
|
| Citadel Advisors | 58k | $15k | 100% | Dec 2023 |
|
| Two Sigma Securities | 37k | $9.5k | 20% | Dec 2023 |
|
| Hrt Financial | 34k | $8.0k | 100% | Dec 2023 |
|
| Goldman Sachs Group | 23k | $5.8k | 119% | Dec 2023 |
|
| Moss Adams Wealth Advisors | 20k | $5.1k | 0% | Dec 2023 |
|
| Jane Street | 19k | $4.9k | 100% | Dec 2023 |
|
| UBS Group | 15k | $3.5k | 67% | Dec 2023 |
|
| Royal Bank of Canada | 2.2k | $0 | -10% | Dec 2023 |
|
| Bank of America Corporation | 1.1k | $0 | 111% | Dec 2023 |
|
| Advisor Group Holdings | 1.0k | $253.233000 | -20% | Dec 2023 |
|
| Jpmorgan Chase & Co | 16.00 | $4.000000 | -73% | Dec 2023 |
|
| Retirement Group | 1.00 | $4.000000 | -98% | Mar 2024 |
|
Who sold out of Gt Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Bank of New York Mellon | Dec 2023 | 95k | $24k |
| Commonwealth Equity Services | Dec 2023 | 10k | $3.0k |
| Welch Group | Dec 2023 | 10k | $2.6k |
| Simplex Trading | Dec 2023 | 304.00 | $0 |
| Blue Bell Private Wealth Management | Dec 2023 | 300.00 | $77.010000 |
| Front Row Advisors | Sep 2023 | 58.00 | $14.001200 |